Guy Thomas Carter - Suffern NY David R. Williams - Stony Point NY Joseph D. Korshalla - Pearl River NY
Assignee:
Roche Vitamins Inc. - Parsippany NJ
International Classification:
A01N 4304 A61K 3171 C07H 1524 C07H 306
US Classification:
514 25
Abstract:
The invention provides an antibiotic designated LL-E19020 Gamma which is derived from the microorganism Streptomyces lydicus ssp. tanzanius NRRL 18036.
Guy Thomas Carter - Suffern NY David R. Williams - Stony Point NY Joseph D. Korshalla - Pearl River NY
Assignee:
Roche Vitamins Inc. - Parsippany NJ
International Classification:
A61K 3170 C07H 306
US Classification:
514 25
Abstract:
The invention provides an antibiotic designated LL-E19020 Alpha. sub. 1 which is derived from the micro-organism Streptomyces lydicus ssp. tanzanius NRRL 18036.
John H. E. J. Martin - New City NY David P. Labeda - Monsey NY Joseph D. Korshalla - Pearl River NY Donald B. Borders - Suffern NY Raymond T. Testa - Cedar Grove NJ
Assignee:
American Cyanamid Company - Stamford CT
International Classification:
C12P 2104 C12P 1718 C12N 120 C12R 1465
US Classification:
435 71
Abstract:
This disclosure describes a novel process for the production of the known antibiotic nosiheptide using a new strain of Streptomyces glaucogriseus and mutants thereof.